2
|
Gündoğdu E, Mat E, Aboalhasan Y, Yıldız G, Başol G, Tolga Saraçoğlu K, Arslan G, Kale A. V-NOTES hysterectomy under spinal anaesthesia: A pilot study. Facts Views Vis Obgyn 2022; 14:275-282. [DOI: 10.52054/fvvo.14.3.040] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022] Open
Abstract
Background: Spinal anaesthesia has not been widely adopted for laparoscopic surgeries until now. There are a few studies that have shown that spinal anaesthesia is at least as safe as general anaesthesia. The need for additional analgesics can be reduced by utilising early postoperative analgesic effects of spinal anaesthesia, and maximum benefit can be obtained from minimally invasive approaches when V-NOTES surgery is performed under spinal anaesthesia.
Objective: Combining V-NOTES with spinal anaesthesia to improve minimally invasive surgical techniques and provide maximum benefit to patients.
Materials and methods: Patients who were found to have benign pelvic organ pathologies, required a hysterectomy and were considered suitable for V-NOTES hysterectomy under spinal anaesthesia were included in this study. Spinal anaesthesia was achieved with 12.5 mg 0.5% hyperbaric bupivacaine in the sitting position. Perioperative events and complications related to spinal anaesthesia were noted. Postoperatively, the pain was evaluated using a visual analogue scale at the 6th, 12th, and 24th hours.
Main outcome measures: To evaluate the feasibility and safety of spinal anaesthesia in VNOTES hysterectomy and to increase the advantages of minimally invasive surgical procedures. Results: No conversion to conventional laparoscopy or laparotomy was required in all six operated patients. Conversion from spinal anaesthesia to general anaesthesia was unnecessary, and no major perioperative incident occurred in any of the cases.
Conclusion: In the current study by our team, we demonstrated that V-NOTES hysterectomy could be performed safely under spinal anaesthesia in well-selected patients. The need for additional analgesics can be reduced by utilising early postoperative analgesic effects of spinal anaesthesia, and maximum benefit can be obtained from minimally invasive approaches when VNOTES surgery is performed under spinal anaesthesia.
What is new? V-NOTES hysterectomy could be performed safely under spinal anaesthesia in well-selected patients.
Collapse
|
3
|
Yazıcıoğlu B, Bakkaloğlu SA, Abranches M, Akman S, Alpay H, Ariceta G, Atmış B, Bael A, Bakkaloğlu SA, Bayrakçı US, Bhimma R, Bjerre A, Bonzel KE, Çeleğen K, Delibaş A, Demircioğlu B, Dursun I, Ertan P, Flögelova H, Gülleroğlu K, Gürgöze MK, Hacıhamdioğlu DÖ, Haffner D, Hansen PR, Jankauskiene A, Jobs K, Kopač M, Liebau MC, Marks SD, Maxted A, Nalçacıoğlu H, Oh J, Özçelik G, Papalia TSS, Papizh S, Poyrazoğlu H, Prikhodina L, Schmidt IM, Schmitt CP, Shroff R, Sönmez F, Stabouli S, Szczepanska M, Tabel Y, Tasic V, Teixeira A, Topaloğlu R, Walle JV, Vidal E, Vondrak K, Yavaşcan Ö, Yazıcıoğlu B, Yıldız G, Yılmaz D, Zaloszyc A, Zieg J. Correction to: Impact of coronavirus disease-2019 on pediatric nephrology practice and education: an ESPN survey. Pediatr Nephrol 2022; 37:1943-1944. [PMID: 35211799 PMCID: PMC8869343 DOI: 10.1007/s00467-022-05473-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
Affiliation(s)
- Burcu Yazıcıoğlu
- grid.25769.3f0000 0001 2169 7132Department of Pediatric Nephrology, Gazi University School of Medicine, Ankara, Turkey
| | - Sevcan A. Bakkaloğlu
- grid.25769.3f0000 0001 2169 7132Department of Pediatric Nephrology, Gazi University School of Medicine, Ankara, Turkey
| | | | - M Abranches
- Department of Pediatric Nephrology, Gazi University School of Medicine, Ankara, Turkey
| | - S Akman
- Department of Pediatric Nephrology, Gazi University School of Medicine, Ankara, Turkey
| | - H Alpay
- Department of Pediatric Nephrology, Gazi University School of Medicine, Ankara, Turkey
| | - G Ariceta
- Department of Pediatric Nephrology, Gazi University School of Medicine, Ankara, Turkey
| | - B Atmış
- Department of Pediatric Nephrology, Gazi University School of Medicine, Ankara, Turkey
| | - A Bael
- Department of Pediatric Nephrology, Gazi University School of Medicine, Ankara, Turkey
| | - S A Bakkaloğlu
- Department of Pediatric Nephrology, Gazi University School of Medicine, Ankara, Turkey
| | - U S Bayrakçı
- Department of Pediatric Nephrology, Gazi University School of Medicine, Ankara, Turkey
| | - R Bhimma
- Department of Pediatric Nephrology, Gazi University School of Medicine, Ankara, Turkey
| | - A Bjerre
- Department of Pediatric Nephrology, Gazi University School of Medicine, Ankara, Turkey
| | - K E Bonzel
- Department of Pediatric Nephrology, Gazi University School of Medicine, Ankara, Turkey
| | - K Çeleğen
- Department of Pediatric Nephrology, Gazi University School of Medicine, Ankara, Turkey
| | - A Delibaş
- Department of Pediatric Nephrology, Gazi University School of Medicine, Ankara, Turkey
| | - B Demircioğlu
- Department of Pediatric Nephrology, Gazi University School of Medicine, Ankara, Turkey
| | - I Dursun
- Department of Pediatric Nephrology, Gazi University School of Medicine, Ankara, Turkey
| | - P Ertan
- Department of Pediatric Nephrology, Gazi University School of Medicine, Ankara, Turkey
| | - H Flögelova
- Department of Pediatric Nephrology, Gazi University School of Medicine, Ankara, Turkey
| | - K Gülleroğlu
- Department of Pediatric Nephrology, Gazi University School of Medicine, Ankara, Turkey
| | - M K Gürgöze
- Department of Pediatric Nephrology, Gazi University School of Medicine, Ankara, Turkey
| | - D Ö Hacıhamdioğlu
- Department of Pediatric Nephrology, Gazi University School of Medicine, Ankara, Turkey
| | - D Haffner
- Department of Pediatric Nephrology, Gazi University School of Medicine, Ankara, Turkey
| | - P R Hansen
- Department of Pediatric Nephrology, Gazi University School of Medicine, Ankara, Turkey
| | - A Jankauskiene
- Department of Pediatric Nephrology, Gazi University School of Medicine, Ankara, Turkey
| | - K Jobs
- Department of Pediatric Nephrology, Gazi University School of Medicine, Ankara, Turkey
| | - M Kopač
- Department of Pediatric Nephrology, Gazi University School of Medicine, Ankara, Turkey
| | - M C Liebau
- Department of Pediatric Nephrology, Gazi University School of Medicine, Ankara, Turkey
| | - S D Marks
- Department of Pediatric Nephrology, Gazi University School of Medicine, Ankara, Turkey
| | - A Maxted
- Department of Pediatric Nephrology, Gazi University School of Medicine, Ankara, Turkey
| | - H Nalçacıoğlu
- Department of Pediatric Nephrology, Gazi University School of Medicine, Ankara, Turkey
| | - J Oh
- Department of Pediatric Nephrology, Gazi University School of Medicine, Ankara, Turkey
| | - G Özçelik
- Department of Pediatric Nephrology, Gazi University School of Medicine, Ankara, Turkey
| | - T S S Papalia
- Department of Pediatric Nephrology, Gazi University School of Medicine, Ankara, Turkey
| | - S Papizh
- Department of Pediatric Nephrology, Gazi University School of Medicine, Ankara, Turkey
| | - H Poyrazoğlu
- Department of Pediatric Nephrology, Gazi University School of Medicine, Ankara, Turkey
| | - L Prikhodina
- Department of Pediatric Nephrology, Gazi University School of Medicine, Ankara, Turkey
| | - I M Schmidt
- Department of Pediatric Nephrology, Gazi University School of Medicine, Ankara, Turkey
| | - C P Schmitt
- Department of Pediatric Nephrology, Gazi University School of Medicine, Ankara, Turkey
| | - R Shroff
- Department of Pediatric Nephrology, Gazi University School of Medicine, Ankara, Turkey
| | - F Sönmez
- Department of Pediatric Nephrology, Gazi University School of Medicine, Ankara, Turkey
| | - S Stabouli
- Department of Pediatric Nephrology, Gazi University School of Medicine, Ankara, Turkey
| | - M Szczepanska
- Department of Pediatric Nephrology, Gazi University School of Medicine, Ankara, Turkey
| | - Y Tabel
- Department of Pediatric Nephrology, Gazi University School of Medicine, Ankara, Turkey
| | - V Tasic
- Department of Pediatric Nephrology, Gazi University School of Medicine, Ankara, Turkey
| | - A Teixeira
- Department of Pediatric Nephrology, Gazi University School of Medicine, Ankara, Turkey
| | - R Topaloğlu
- Department of Pediatric Nephrology, Gazi University School of Medicine, Ankara, Turkey
| | - J Vande Walle
- Department of Pediatric Nephrology, Gazi University School of Medicine, Ankara, Turkey
| | - E Vidal
- Department of Pediatric Nephrology, Gazi University School of Medicine, Ankara, Turkey
| | - K Vondrak
- Department of Pediatric Nephrology, Gazi University School of Medicine, Ankara, Turkey
| | - Ö Yavaşcan
- Department of Pediatric Nephrology, Gazi University School of Medicine, Ankara, Turkey
| | - B Yazıcıoğlu
- Department of Pediatric Nephrology, Gazi University School of Medicine, Ankara, Turkey
| | - G Yıldız
- Department of Pediatric Nephrology, Gazi University School of Medicine, Ankara, Turkey
| | - D Yılmaz
- Department of Pediatric Nephrology, Gazi University School of Medicine, Ankara, Turkey
| | - A Zaloszyc
- Department of Pediatric Nephrology, Gazi University School of Medicine, Ankara, Turkey
| | - J Zieg
- Department of Pediatric Nephrology, Gazi University School of Medicine, Ankara, Turkey
| |
Collapse
|
4
|
Aydın OD, Yıldız G, Merhan O, Bulut SU, Tarhane AK, Ambarcıoğlu P, Sezer M, Akyüz E. Use of Lactobacillus farciminis to improve antioxidant status of Tuj lambs. S AFR J ANIM SCI 2021. [DOI: 10.4314/sajas.v51i4.11] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
The aim of this study was to investigate the effects of Lactobacillus farciminis on growth traits and antioxidant status in preweaning and postweaning Tuj lambs. Twenty lambs were divided into four groups, regardless of gender, with a mean live weight of 7.81 ± 0.50 kg. At the start of the experiment, the average age of the lambs was seven days. During the six-week preweaning period, control (C) lambs were fed with colostrum only, and Lactobacillus farciminis was given orally to the treated lambs at 1 g/day/lamb (L1), 2 g/day/lamb (L2) or 4 g/day/lamb (L3). The experiment continued for a total of 22 weeks. During the first six weeks, bodyweight (BW) increased significantly in L1 at the sixth week. Also during this period, bodyweight gain (BWG) in L2 at 2 - 3 weeks and in L3 at 5 - 6 weeks differed from C. In the subsequent period, BW and BWG were not affected by probiotic supplementation. The effects of probiotic supplementation on malondialdehyde (MDA), nitric oxide (NO), superoxide dismutase (SOD), glutathione peroxidase (GPx), and catalase (CAT) were significant throughout the experiment, with the effect on glutathione (GSH) also being important in the first six weeks. Thus, Lactobacillus farciminis provided orally to Tuj breed lambs could be used to improve their antioxidant status without compromising growth.
Collapse
|
6
|
Soylu Ustkoyuncu P, Gokay S, Eren E, Dogan D, Yıldız G, Yılmaz A, Mutlu FT. Novel MTTP Gene Mutation in a Case of Abetalipoproteinemia with Central Hypothyroidism. J Clin Res Pediatr Endocrinol 2020; 12:427-431. [PMID: 31914726 PMCID: PMC7711635 DOI: 10.4274/jcrpe.galenos.2019.2019.0144] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/08/2023] Open
Abstract
Abetalipoproteinaemia (ABL) is an autosomal recessive disorder characterized by very low plasma concentrations of total cholesterol and triglyceride (TG). It results from mutations in the gene encoding microsomal TG transfer protein (MTTP). A nine-month-old girl was admitted to hospital because of fever, cough, diarrhea and failure to thrive. She had low cholesterol and TG levels according to her age. The peripheral blood smear revealed acanthocytosis. Thyroid function test showed central hypothyroidism. Cranial magnetic resonance imaging revealed the retardation of myelination and pituitary gland height was 1.7 mm. A homozygous novel mutation [c.506A>T (p.D169V)] was detected in the MTTP gene. Vitamins A, D, E, and K and levothyroxine were started. The coexistence of ABL and central hypothyroidism has not previously been reported. A homozygous novel mutation [c.506A>T (p.D169V)] was detected in the MTTP gene.
Collapse
Affiliation(s)
- Pembe Soylu Ustkoyuncu
- Kayseri City Hospital, Clinic of Pediatric Nutrition and Metabolism, Kayseri, Turkey,* Address for Correspondence: Kayseri City Hospital, Clinic of Pediatric Nutrition and Metabolism, Kayseri, Turkey Phone: +90 352 315 77 00/40176 E-mail:
| | - Songül Gokay
- Kayseri City Hospital, Clinic of Pediatric Nutrition and Metabolism, Kayseri, Turkey
| | - Esra Eren
- Kayseri City Hospital, Clinic of Pediatric Gastroenterology, Hepatology and Nutrition, Kayseri, Turkey
| | - Durmus Dogan
- Kayseri City Hospital, Clinic of Pediatric Endocrinology, Kayseri, Turkey
| | - Gokce Yıldız
- Kayseri City Hospital, Clinic of Pediatrics, Kayseri, Turkey
| | - Aysegul Yılmaz
- Kayseri City Hospital, Clinic of Pediatric Genetic, Kayseri, Turkey
| | - Fatma Turkan Mutlu
- Kayseri City Hospital, Clinic of Pediatric Hematology and Oncology, Kayseri, Turkey
| |
Collapse
|
7
|
Abstract
The present study aimed to determine the level of felt stigma, overprotection, concealment, and concerns related to epilepsy in different life domains by using culturally-specific scales for Turkish individuals with epilepsy. Also, it aimed to detect relations among the study variables and to determine the variables which predict felt stigma. For this purpose, felt stigma scale, overprotection scale, concealment of epilepsy scale, and concerns of epilepsy scale were administered to two hundred adult persons with epilepsy (PWE). The results showed that almost half of the participants reported felt stigma, overprotection, concealment of epilepsy, concerns related to future occupation, and concerns related to social life. Almost all the study variables show correlations with each other. Concealment of epilepsy, concerns related to social life, and concerns related to future occupation were found as the predictors of felt stigma.
Collapse
Affiliation(s)
- N Aydemir
- Izmir University of Economics, Department of Psychology, Izmir 35330, Turkey.
| | - B Kaya
- Izmir University of Economics, Department of Psychology, Izmir 35330, Turkey
| | - G Yıldız
- Izmir University of Economics, Department of Psychology, Izmir 35330, Turkey
| | - I Öztura
- Dokuz Eylül University, School of Medicine, Department of Neurology, Izmir, Turkey
| | - B Baklan
- Dokuz Eylül University, School of Medicine, Department of Neurology, Izmir, Turkey
| |
Collapse
|
10
|
Celik EU, Yıldız G, Yazkan B. Comparison of enamel microabrasion with a combined approach to the esthetic management of fluorosed teeth. Oper Dent 2013; 38:E134-43. [PMID: 23391032 DOI: 10.2341/12-317-c] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
Abstract
OBJECTIVE To compare in vivo the efficacy of enamel microabrasion alone or in combination with vital tooth bleaching for the management of tooth discoloration caused by fluorosis. METHODS A total of 118 maxillary and mandibular fluorosed incisors and canines in 10 patients, scored from 1 to 7 according to the Tooth Surface Index of Fluorosis, were included in this study. All of the teeth were initially treated with enamel microabrasion (Opalustre, Ultradent Products Inc, South Jordan, UT, USA), and after 24 hours, an in-office bleaching technique (Opalescence Boost, Ultradent) was utilized (n=118). Standardized images of the teeth were taken using a digital camera prior to treatment and 24 hours after the enamel microabrasion and after the in-office bleaching therapy. The study groups were assigned according to evaluation time: a) after enamel microabrasion (Group 1) and b) after the combined approach (enamel microabrasion and in-office bleaching) (Group 2). Two calibrated and blinded examiners scored Group 1 and Group 2 images by comparing each with baseline images for "improvement in appearance," "changes in brown stains," and "changes in white opaque areas" using the visual analogue scales (VAS) that range from 1 to 7. "Patient satisfaction," "tooth sensitivity," and "gingival problems" were also recorded. The data were analyzed using two sample paired Wilcoxon signed-rank, Kruskal-Wallis, and Mann-Whitney U-tests (α=0.05). RESULTS The combined therapy revealed significantly higher scores than the enamel microabrasion procedure in terms of all of the evaluated criteria (p<0.001). Enamel microabrasion provoked less tooth sensitivity but led to lower patient satisfaction scores than the combined therapy (p<0.001); however, in terms of gingival problems, no differences were found between both groups. CONCLUSION The combined therapy, including enamel microabrasion and in-office bleaching, was more effective than enamel microabrasion alone in the esthetic management of fluorosed teeth.
Collapse
|